Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Abstract Adenoviral vectors have been explored as vaccine agents for a range of infectious diseases, and their ability to induce a potent and balanced immune response made them logical candidates to apply to the COVID-19 pandemic. The unique molecular characteristics of these vectors enabled the rap...
Enregistré dans:
Auteurs principaux: | Samir Andrade Mendonça, Reka Lorincz, Paul Boucher, David T. Curiel |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2884d62b3ff9428ba246fbb13c87a66c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Viral vector-based vaccines against SARS-CoV-2
par: Kenneth Lundstrom
Publié: (2021) -
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
par: L. V. Cherenova, et autres
Publié: (2017) -
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
par: L. V. Cherenova, et autres
Publié: (2017) -
Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic
par: Charles Yap, et autres
Publié: (2021) -
MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
par: Clement A. Meseda, et autres
Publié: (2021)